Repligen Corporation Common Stock (NASDAQ: RGEN) last traded at $181.13, up 0.47% on the session. The quote above updates while this page is open; the figures below are drawn from Repligen Corporation Common Stock’s own filings and are restated only when a new one is published.
Repligen Corporation Common Stock trades on NASDAQ under the ticker RGEN. Its market capitalisation is $10.22 billion.
Valuation measures for Repligen Corporation Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $10.22B |
|---|---|
| Enterprise value | $10.45B |
| P/E ratio | 244.77 |
| Price / sales | 13.02 |
| Price / book | 4.84 |
| Beta | 1.21 |
Trailing-twelve-month figures tagged in Repligen Corporation Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $785.10M |
|---|---|
| Net income (TTM) | $41.54M |
| EPS (TTM) | $0.740 |
| Operating margin | 8.23% |
| Return on equity | 1.97% |
| Cash | $606.78M |
Range and volume for RGEN over the past 52 weeks.
| 52-week high | $188.73 |
|---|---|
| 52-week low | $100.99 |
| Volume | 1.09M |
| Average volume | 1.11M |
| Previous close | $180.29 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.